Microporous and Mesoporous Materials and Their Derived Hybrids as Systems for Controlled Release
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: closed (10 February 2022) | Viewed by 22804
Special Issue Editors
Interests: biomaterials; porous materials; biopolymers; hybrids; nanostructured materials; nanofilms; controlled release
Interests: preparation, functionalization and applications of biocompatible mesoporous semiconductors
Special Issue Information
Dear Colleagues,
In recent decades, a diversity of materials such as polymers, ceramics, and semiconductors have been used as controlled release systems. Among the most versatile materials, microporous and mesoporous materials stand out due to their high surface areas and tailorable surface chemistry. Depending on the size and surface functionalization of the pores, increased or sustained controlled release of a loaded molecule can be obtained. Moreover, if these micro- and mesoporous materials are inorganic, hybrids can be synthetized through a combination with organic compounds such as biopolymers. Engineered hybrid materials exhibit new advantageous chemical and physical characteristics, which are not exhibited by the individual constituents. Particularly, improved control over drug release kinetics, enhanced stability in different media, and selective release can be achieved by gating the pores with responsive molecules.
Microporous- and mesoporous-based materials and their derived hybrids work for several molecules such as drugs, proteins, genes, fertilizers, nutrients, salts, and other biologically active agents.
Dr. Jacobo Hernández Montelongo
Dr. Miguel Manso Silván
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- microporous
- mesoporous
- hybrids
- controlled release
- drug delivery